Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Rucaparib> ?p ?o }
Showing triples 1 to 55 of
55
with 100 triples per page.
- Rucaparib abstract "Rucaparib (AG 014699) is a PARP inhibitor being investigated as a potential anti-cancer agent. Rucaparib is the first-in-class clinical candidate targeting the DNA repair enzyme poly-ADPribose polymerase-1 (PARP-1), and was first synthesised as part of a collaboration between scientists working in Northern Institute of Cancer Research and Medical School of Newcastle University, alongside Agouron Pharmaceuticals (San Diego).Rucaparib inhibits \"the contraction of isolated vascular smooth muscle, including that from the tumours of cancer patients. It also reduces the migration of some cancer and normal cells in culture.\"It can be taken orally in tablet form.It has undergone phase I clinical trials for patients with advanced solid tumours. It is in phase II clinical trials for metastatic breast and ovarian cancer with known BRCA1 or BRCA2 mutation.It is thought that 20% of women with ovarian cancer who are not BRCA positive might also benefit from PARP inhibitors. Clinical trials are beginning (as of April, 2014)As of November 2012 four clinical trials of rucaparib were recruiting patients.".
- Rucaparib iupacName "8-Fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one".
- Rucaparib thumbnail Rucaparib.svg?width=300.
- Rucaparib wikiPageID "25111638".
- Rucaparib wikiPageLength "3023".
- Rucaparib wikiPageOutDegree "10".
- Rucaparib wikiPageRevisionID "688989263".
- Rucaparib wikiPageWikiLink BRCA1.
- Rucaparib wikiPageWikiLink BRCA2.
- Rucaparib wikiPageWikiLink Breast_cancer.
- Rucaparib wikiPageWikiLink Category:Indoles.
- Rucaparib wikiPageWikiLink Category:Lactams.
- Rucaparib wikiPageWikiLink Category:PARP_inhibitors.
- Rucaparib wikiPageWikiLink Neoplasm.
- Rucaparib wikiPageWikiLink Ovarian_cancer.
- Rucaparib wikiPageWikiLink PARP_inhibitor.
- Rucaparib wikiPageWikiLink Phases_of_clinical_research.
- Rucaparib wikiPageWikiLinkText "Rucaparib".
- Rucaparib imagefile "Rucaparib.svg".
- Rucaparib imagesize "200".
- Rucaparib iupacname "8".
- Rucaparib othernames "AG014699".
- Rucaparib wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Rucaparib wikiPageUsesTemplate Template:As_of.
- Rucaparib wikiPageUsesTemplate Template:Cascite.
- Rucaparib wikiPageUsesTemplate Template:Chembox.
- Rucaparib wikiPageUsesTemplate Template:Chembox_Hazards.
- Rucaparib wikiPageUsesTemplate Template:Chembox_Identifiers.
- Rucaparib wikiPageUsesTemplate Template:Chembox_Properties.
- Rucaparib wikiPageUsesTemplate Template:Keggcite.
- Rucaparib wikiPageUsesTemplate Template:Reflist.
- Rucaparib subject Category:Indoles.
- Rucaparib subject Category:Lactams.
- Rucaparib subject Category:PARP_inhibitors.
- Rucaparib hypernym Inhibitor.
- Rucaparib type ChemicalCompound.
- Rucaparib type ChemicalSubstance.
- Rucaparib type Drug.
- Rucaparib type Amide.
- Rucaparib type Heterocycle.
- Rucaparib type Inhibitor.
- Rucaparib type Lactam.
- Rucaparib type ChemicalObject.
- Rucaparib type Thing.
- Rucaparib type Q11173.
- Rucaparib comment "Rucaparib (AG 014699) is a PARP inhibitor being investigated as a potential anti-cancer agent.".
- Rucaparib label "Rucaparib".
- Rucaparib sameAs Q7376558.
- Rucaparib sameAs m.09gq70b.
- Rucaparib sameAs Rukaparib.
- Rucaparib sameAs Rukaparib.
- Rucaparib sameAs Q7376558.
- Rucaparib wasDerivedFrom Rucaparib?oldid=688989263.
- Rucaparib depiction Rucaparib.svg.
- Rucaparib isPrimaryTopicOf Rucaparib.